Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
105774302 | 10577430 | 2 | F | 20141105 | 20160926 | 20141111 | 20160930 | EXP | IT-AIFA-278119 | IT-ELI_LILLY_AND_COMPANY-IT201411002777 | ELI LILLY AND CO | 42.18 | YR | M | Y | 0.00000 | 20160930 | CN | IT | IT |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
105774302 | 10577430 | 1 | PS | ZYPADHERA | OLANZAPINE PAMOATE | 1 | Intramuscular | UNK UNK, MONTHLY (1/M) | Y | 22173 | INJECTION | /month | |||||||
105774302 | 10577430 | 2 | SS | ZYPADHERA | OLANZAPINE PAMOATE | 1 | Y | 22173 | INJECTION | ||||||||||
105774302 | 10577430 | 3 | SS | ZYPADHERA | OLANZAPINE PAMOATE | 1 | Y | 22173 | INJECTION |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
105774302 | 10577430 | 1 | Mental disorder |
105774302 | 10577430 | 2 | Mental disorder |
105774302 | 10577430 | 3 | Schizophrenia |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
105774302 | 10577430 | HO |
105774302 | 10577430 | LT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
105774302 | 10577430 | Blood pressure diastolic increased | |
105774302 | 10577430 | Coma | |
105774302 | 10577430 | Discomfort | |
105774302 | 10577430 | Sopor |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |